Loading…
Effect of CD40 ligand on the course of murine histoplasmosis
CD40 ligand-CD40 ligation is important in the development of T-cell-mediated immune responses. The purpose of this study was to examine the role of CD40L in recovery from histoplasmosis using a murine model of intratracheally induced infection. B6C3F1 mice were infected intratracheally with Histopla...
Saved in:
Published in: | Medical Mycology 2002, Vol.40 (5), p.501-505 |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c3695-3cb793fabe972833c5f37113db4bb2b45f13a33b4329f01650c5321f31c295713 |
---|---|
cites | cdi_FETCH-LOGICAL-c3695-3cb793fabe972833c5f37113db4bb2b45f13a33b4329f01650c5321f31c295713 |
container_end_page | 505 |
container_issue | 5 |
container_start_page | 501 |
container_title | Medical Mycology |
container_volume | 40 |
creator | Wheat, L. J. Durkin, M. Schnizlein-Bick, C. Bassey, E. Kohler, S. Connolly, P. Goldberg, J. Garringer, T. Brizendine, E. Thomas, E. K. |
description | CD40 ligand-CD40 ligation is important in the development of T-cell-mediated immune responses. The purpose of this study was to examine the role of CD40L in recovery from histoplasmosis using a murine model of intratracheally induced infection. B6C3F1 mice were infected intratracheally with Histoplasma capsulatum yeast and monitored for clearance of the organism from the lungs and spleen. CD40L treatment was begun on either day-2 or +2 post inoculation and continued until day 14 in CD4-depleted animals and from day-2 to day +4 in nonimmunosuppressed animals. Amphotericin B treatment was begun four days following inoculation and given every other day for 10 days. CD40L reduced fungal burden by less than one log when started two days before infection but did not act synergistically with low-dosage amphotericin B (0.2 mg kg-1 qod) in CD4 depleted mice. Low-dose amphotericin B, CD40L, and the combination of the two failed to lower the fungal burden in a second experiment using a more virulent isolate of the same strain of H. capsulatum in CD4-depleted mice. Furthermore, CD40L did not increase the concentrations of IFN-γ, IL-12 or IL-10 in the lungs or spleens of infected animals. In summary, CD40L had minimal or no effect on the course of infection in this murine model of histoplasmosis. |
doi_str_mv | 10.1080/mmy.40.5.501.505 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72726061</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1080/mmy.40.5.501.505</oup_id><sourcerecordid>72726061</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3695-3cb793fabe972833c5f37113db4bb2b45f13a33b4329f01650c5321f31c295713</originalsourceid><addsrcrecordid>eNqNkD1PwzAQhi0EoqWwM6EssKCUsy-OG8SCSvmQKrHAbDmuTVMlcbGTof8el1bqhMRwsqV73rPvIeSSwpjCBO6aZjPOYMzHHGgsfkSGFHOWIhT8-PdepCgm-YCchbACoKJgeEoGlGU54whD8jCz1ugucTaZPmWQ1NWXaheJa5NuaRLteh_Mttn0vmpNsqxC59a1Co0LVTgnJ1bVwVzszxH5fJ59TF_T-fvL2_Rxnur4AZ6iLkWBVpWmEGyCqLlFQSkuyqwsWZlxS1EhlhmywgLNOWiOjFqkmhVcUByRm93ctXffvQmdbKqgTV2r1rg-SMEEyyHfgrADtXcheGPl2leN8htJQW6NyWhMZiC5jMZi8Ri52s_uy8YsDoG9oghc7wEVtKqtV62uwoHLAEQRtxqR2x3n-vV_nr3f0VVrnW_U0qi6W2rljVxF6W3U-Xf4Bzh6kvo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72726061</pqid></control><display><type>article</type><title>Effect of CD40 ligand on the course of murine histoplasmosis</title><source>Oxford Journals Online</source><source>Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list)</source><creator>Wheat, L. J. ; Durkin, M. ; Schnizlein-Bick, C. ; Bassey, E. ; Kohler, S. ; Connolly, P. ; Goldberg, J. ; Garringer, T. ; Brizendine, E. ; Thomas, E. K.</creator><creatorcontrib>Wheat, L. J. ; Durkin, M. ; Schnizlein-Bick, C. ; Bassey, E. ; Kohler, S. ; Connolly, P. ; Goldberg, J. ; Garringer, T. ; Brizendine, E. ; Thomas, E. K.</creatorcontrib><description>CD40 ligand-CD40 ligation is important in the development of T-cell-mediated immune responses. The purpose of this study was to examine the role of CD40L in recovery from histoplasmosis using a murine model of intratracheally induced infection. B6C3F1 mice were infected intratracheally with Histoplasma capsulatum yeast and monitored for clearance of the organism from the lungs and spleen. CD40L treatment was begun on either day-2 or +2 post inoculation and continued until day 14 in CD4-depleted animals and from day-2 to day +4 in nonimmunosuppressed animals. Amphotericin B treatment was begun four days following inoculation and given every other day for 10 days. CD40L reduced fungal burden by less than one log when started two days before infection but did not act synergistically with low-dosage amphotericin B (0.2 mg kg-1 qod) in CD4 depleted mice. Low-dose amphotericin B, CD40L, and the combination of the two failed to lower the fungal burden in a second experiment using a more virulent isolate of the same strain of H. capsulatum in CD4-depleted mice. Furthermore, CD40L did not increase the concentrations of IFN-γ, IL-12 or IL-10 in the lungs or spleens of infected animals. In summary, CD40L had minimal or no effect on the course of infection in this murine model of histoplasmosis.</description><identifier>ISSN: 1369-3786</identifier><identifier>EISSN: 1362-3095</identifier><identifier>EISSN: 1460-2709</identifier><identifier>DOI: 10.1080/mmy.40.5.501.505</identifier><identifier>PMID: 12462530</identifier><language>eng</language><publisher>UK: Informa UK Ltd</publisher><subject>Animals ; Bacterial diseases ; Biological and medical sciences ; CD4 Antigens - physiology ; CD40 Ligand - physiology ; CD40 Ligand - therapeutic use ; Experimental bacterial diseases and models ; Fundamental and applied biological sciences. Psychology ; Histoplasmosis - drug therapy ; Histoplasmosis - immunology ; Infectious diseases ; Interferon-gamma ; Interleukin-10 - analysis ; Interleukin-12 - analysis ; Lung - immunology ; Medical sciences ; Mice ; Microbiology ; Mycology ; Pathogenicity, host-agent relations, miscellaneous strains, epidemiology</subject><ispartof>Medical Mycology, 2002, Vol.40 (5), p.501-505</ispartof><rights>2002 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 2002</rights><rights>2002 ISHAM 2002</rights><rights>2003 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3695-3cb793fabe972833c5f37113db4bb2b45f13a33b4329f01650c5321f31c295713</citedby><cites>FETCH-LOGICAL-c3695-3cb793fabe972833c5f37113db4bb2b45f13a33b4329f01650c5321f31c295713</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,4021,27921,27922,27923</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=14007983$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12462530$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wheat, L. J.</creatorcontrib><creatorcontrib>Durkin, M.</creatorcontrib><creatorcontrib>Schnizlein-Bick, C.</creatorcontrib><creatorcontrib>Bassey, E.</creatorcontrib><creatorcontrib>Kohler, S.</creatorcontrib><creatorcontrib>Connolly, P.</creatorcontrib><creatorcontrib>Goldberg, J.</creatorcontrib><creatorcontrib>Garringer, T.</creatorcontrib><creatorcontrib>Brizendine, E.</creatorcontrib><creatorcontrib>Thomas, E. K.</creatorcontrib><title>Effect of CD40 ligand on the course of murine histoplasmosis</title><title>Medical Mycology</title><addtitle>Med Mycol</addtitle><description>CD40 ligand-CD40 ligation is important in the development of T-cell-mediated immune responses. The purpose of this study was to examine the role of CD40L in recovery from histoplasmosis using a murine model of intratracheally induced infection. B6C3F1 mice were infected intratracheally with Histoplasma capsulatum yeast and monitored for clearance of the organism from the lungs and spleen. CD40L treatment was begun on either day-2 or +2 post inoculation and continued until day 14 in CD4-depleted animals and from day-2 to day +4 in nonimmunosuppressed animals. Amphotericin B treatment was begun four days following inoculation and given every other day for 10 days. CD40L reduced fungal burden by less than one log when started two days before infection but did not act synergistically with low-dosage amphotericin B (0.2 mg kg-1 qod) in CD4 depleted mice. Low-dose amphotericin B, CD40L, and the combination of the two failed to lower the fungal burden in a second experiment using a more virulent isolate of the same strain of H. capsulatum in CD4-depleted mice. Furthermore, CD40L did not increase the concentrations of IFN-γ, IL-12 or IL-10 in the lungs or spleens of infected animals. In summary, CD40L had minimal or no effect on the course of infection in this murine model of histoplasmosis.</description><subject>Animals</subject><subject>Bacterial diseases</subject><subject>Biological and medical sciences</subject><subject>CD4 Antigens - physiology</subject><subject>CD40 Ligand - physiology</subject><subject>CD40 Ligand - therapeutic use</subject><subject>Experimental bacterial diseases and models</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Histoplasmosis - drug therapy</subject><subject>Histoplasmosis - immunology</subject><subject>Infectious diseases</subject><subject>Interferon-gamma</subject><subject>Interleukin-10 - analysis</subject><subject>Interleukin-12 - analysis</subject><subject>Lung - immunology</subject><subject>Medical sciences</subject><subject>Mice</subject><subject>Microbiology</subject><subject>Mycology</subject><subject>Pathogenicity, host-agent relations, miscellaneous strains, epidemiology</subject><issn>1369-3786</issn><issn>1362-3095</issn><issn>1460-2709</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><recordid>eNqNkD1PwzAQhi0EoqWwM6EssKCUsy-OG8SCSvmQKrHAbDmuTVMlcbGTof8el1bqhMRwsqV73rPvIeSSwpjCBO6aZjPOYMzHHGgsfkSGFHOWIhT8-PdepCgm-YCchbACoKJgeEoGlGU54whD8jCz1ugucTaZPmWQ1NWXaheJa5NuaRLteh_Mttn0vmpNsqxC59a1Co0LVTgnJ1bVwVzszxH5fJ59TF_T-fvL2_Rxnur4AZ6iLkWBVpWmEGyCqLlFQSkuyqwsWZlxS1EhlhmywgLNOWiOjFqkmhVcUByRm93ctXffvQmdbKqgTV2r1rg-SMEEyyHfgrADtXcheGPl2leN8htJQW6NyWhMZiC5jMZi8Ri52s_uy8YsDoG9oghc7wEVtKqtV62uwoHLAEQRtxqR2x3n-vV_nr3f0VVrnW_U0qi6W2rljVxF6W3U-Xf4Bzh6kvo</recordid><startdate>2002</startdate><enddate>2002</enddate><creator>Wheat, L. J.</creator><creator>Durkin, M.</creator><creator>Schnizlein-Bick, C.</creator><creator>Bassey, E.</creator><creator>Kohler, S.</creator><creator>Connolly, P.</creator><creator>Goldberg, J.</creator><creator>Garringer, T.</creator><creator>Brizendine, E.</creator><creator>Thomas, E. K.</creator><general>Informa UK Ltd</general><general>Taylor & Francis</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>2002</creationdate><title>Effect of CD40 ligand on the course of murine histoplasmosis</title><author>Wheat, L. J. ; Durkin, M. ; Schnizlein-Bick, C. ; Bassey, E. ; Kohler, S. ; Connolly, P. ; Goldberg, J. ; Garringer, T. ; Brizendine, E. ; Thomas, E. K.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3695-3cb793fabe972833c5f37113db4bb2b45f13a33b4329f01650c5321f31c295713</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Animals</topic><topic>Bacterial diseases</topic><topic>Biological and medical sciences</topic><topic>CD4 Antigens - physiology</topic><topic>CD40 Ligand - physiology</topic><topic>CD40 Ligand - therapeutic use</topic><topic>Experimental bacterial diseases and models</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Histoplasmosis - drug therapy</topic><topic>Histoplasmosis - immunology</topic><topic>Infectious diseases</topic><topic>Interferon-gamma</topic><topic>Interleukin-10 - analysis</topic><topic>Interleukin-12 - analysis</topic><topic>Lung - immunology</topic><topic>Medical sciences</topic><topic>Mice</topic><topic>Microbiology</topic><topic>Mycology</topic><topic>Pathogenicity, host-agent relations, miscellaneous strains, epidemiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wheat, L. J.</creatorcontrib><creatorcontrib>Durkin, M.</creatorcontrib><creatorcontrib>Schnizlein-Bick, C.</creatorcontrib><creatorcontrib>Bassey, E.</creatorcontrib><creatorcontrib>Kohler, S.</creatorcontrib><creatorcontrib>Connolly, P.</creatorcontrib><creatorcontrib>Goldberg, J.</creatorcontrib><creatorcontrib>Garringer, T.</creatorcontrib><creatorcontrib>Brizendine, E.</creatorcontrib><creatorcontrib>Thomas, E. K.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Medical Mycology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wheat, L. J.</au><au>Durkin, M.</au><au>Schnizlein-Bick, C.</au><au>Bassey, E.</au><au>Kohler, S.</au><au>Connolly, P.</au><au>Goldberg, J.</au><au>Garringer, T.</au><au>Brizendine, E.</au><au>Thomas, E. K.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effect of CD40 ligand on the course of murine histoplasmosis</atitle><jtitle>Medical Mycology</jtitle><addtitle>Med Mycol</addtitle><date>2002</date><risdate>2002</risdate><volume>40</volume><issue>5</issue><spage>501</spage><epage>505</epage><pages>501-505</pages><issn>1369-3786</issn><eissn>1362-3095</eissn><eissn>1460-2709</eissn><abstract>CD40 ligand-CD40 ligation is important in the development of T-cell-mediated immune responses. The purpose of this study was to examine the role of CD40L in recovery from histoplasmosis using a murine model of intratracheally induced infection. B6C3F1 mice were infected intratracheally with Histoplasma capsulatum yeast and monitored for clearance of the organism from the lungs and spleen. CD40L treatment was begun on either day-2 or +2 post inoculation and continued until day 14 in CD4-depleted animals and from day-2 to day +4 in nonimmunosuppressed animals. Amphotericin B treatment was begun four days following inoculation and given every other day for 10 days. CD40L reduced fungal burden by less than one log when started two days before infection but did not act synergistically with low-dosage amphotericin B (0.2 mg kg-1 qod) in CD4 depleted mice. Low-dose amphotericin B, CD40L, and the combination of the two failed to lower the fungal burden in a second experiment using a more virulent isolate of the same strain of H. capsulatum in CD4-depleted mice. Furthermore, CD40L did not increase the concentrations of IFN-γ, IL-12 or IL-10 in the lungs or spleens of infected animals. In summary, CD40L had minimal or no effect on the course of infection in this murine model of histoplasmosis.</abstract><cop>UK</cop><pub>Informa UK Ltd</pub><pmid>12462530</pmid><doi>10.1080/mmy.40.5.501.505</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1369-3786 |
ispartof | Medical Mycology, 2002, Vol.40 (5), p.501-505 |
issn | 1369-3786 1362-3095 1460-2709 |
language | eng |
recordid | cdi_proquest_miscellaneous_72726061 |
source | Oxford Journals Online; Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list) |
subjects | Animals Bacterial diseases Biological and medical sciences CD4 Antigens - physiology CD40 Ligand - physiology CD40 Ligand - therapeutic use Experimental bacterial diseases and models Fundamental and applied biological sciences. Psychology Histoplasmosis - drug therapy Histoplasmosis - immunology Infectious diseases Interferon-gamma Interleukin-10 - analysis Interleukin-12 - analysis Lung - immunology Medical sciences Mice Microbiology Mycology Pathogenicity, host-agent relations, miscellaneous strains, epidemiology |
title | Effect of CD40 ligand on the course of murine histoplasmosis |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T22%3A01%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effect%20of%20CD40%20ligand%20on%20the%20course%20of%20murine%20histoplasmosis&rft.jtitle=Medical%20Mycology&rft.au=Wheat,%20L.%20J.&rft.date=2002&rft.volume=40&rft.issue=5&rft.spage=501&rft.epage=505&rft.pages=501-505&rft.issn=1369-3786&rft.eissn=1362-3095&rft_id=info:doi/10.1080/mmy.40.5.501.505&rft_dat=%3Cproquest_cross%3E72726061%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3695-3cb793fabe972833c5f37113db4bb2b45f13a33b4329f01650c5321f31c295713%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=72726061&rft_id=info:pmid/12462530&rft_oup_id=10.1080/mmy.40.5.501.505&rfr_iscdi=true |